Microbiosensor and method for using same to reduce measurement interference - Patents.com

The microbiosensor with dual electrodes addresses interference in glucose monitoring by using a second electrode to consume interferents, improving measurement accuracy by up to 90% and reducing errors to less than 10% in both in vitro and in vivo tests.

JP7595045B2Active Publication Date: 2024-12-05BIONIME
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2022109556
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-03-12
Filing Date
2022-07-07
Publication Date
2024-12-05
Estimated Expiration
2040-08-03

AI Technical Summary

Technical Problem

Existing continuous blood glucose monitoring systems face interference from substances like ascorbic acid, acetaminophen, uric acid, and proteins, which affect the accuracy of glucose measurements due to similar oxidation potentials, necessitating a method to reduce such interference.

Method used

A microbiosensor with two working electrodes, one using a first conductive material for accurate glucose measurement and another using a second conductive material with lower sensitivity to interferents, which consumes these substances, reducing interference by generating an interference cancellation range that overlaps with the measurement range.

Benefits of technology

The microbiosensor effectively minimizes interference from substances like acetaminophen, enhancing the accuracy of glucose concentration measurements by up to 90% and reducing errors to less than 10% in both in vitro and in vivo tests.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007595045000001
    Figure 0007595045000001
  • Figure 0007595045000002
    Figure 0007595045000002
  • Figure 0007595045000003
    Figure 0007595045000003
Patent Text Reader

Abstract

The present invention provides a microbiosensor for reducing measurement interference when measuring a target analyte in a biological fluid. The microbiosensor includes a substrate, a first working electrode disposed on the surface and including a first sensing moiety, a second working electrode disposed on the surface and including a second sensing moiety disposed adjacent to at least one side of the first sensing moiety, and a chemical reagent covering at least a portion of the first conductive material for reacting with the target analyte to produce a resultant. When the first working electrode is driven by a first working voltage, the first sensing moiety measures a physiological signal corresponding to the target analyte. When the second working electrode is driven by a second working voltage, the second conductive material can directly consume interferents to continuously reduce interference with the measurement of the physiological signal.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS AND PRIORITY CLAIMS This application claims the benefit of the filing dates of U.S. Provisional Patent Application No. 62 / 882,162, filed August 2, 2019, and U.S. Provisional Patent Application No. 62 / 988,549, filed March 12, 2020, the disclosures of which are incorporated by reference in their entireties herein.

[0002] The present invention relates to a microbiosensor, and in particular to a microbiosensor and method for reducing measurement interference when measuring a target analyte in a biological fluid. [Background technology]

[0003] According to the rapid increase in the population of chronic patients, the detection of analytes in biological fluids in vivo is of great importance for the diagnosis and monitoring of patients. In particular, effectively monitoring glucose concentrations in the body is key to the treatment of diabetes. Therefore, continuous glucose monitoring (CGM) systems have attracted attention in recent years. This system has many advantages over traditional biosensors, such as the absence of pain caused by sampling blood on a finger and the continuous monitoring of physiological parameters of one or more target analytes in biological fluids.

[0004] Continuous glucose monitoring systems include enzyme-based biosensors that are used to measure physiological signals corresponding to glucose concentrations in the body. Specifically, glucose oxidase (GOx) catalyzes the glucose reaction to produce gluconolactone and reductase. The reductase transfers electrons from oxygen in biological fluids in the body to produce the by-product hydrogen peroxide (H2O2), which quantifies the glucose concentration by catalyzing the oxidation reaction of the by-product H2O2. However, in the presence of interfering substances such as ascorbic acid (AA), the main component of vitamin C, acetaminophen (AM), a common component of painkillers, uric acid (UA), proteins and glucose analogues in blood or tissue fluids, the oxidation potential of the interfering substances is close to that of H2O2, producing electrochemical signals that are unrelated to the compounds of interest. Such interfering signals need to be reduced so that measurements of physiological parameters can be reliable.

[0005] Therefore, the applicant seeks to address the above situation encountered in the prior art. Summary of the Invention [Problem to be solved by the invention]

[0006] The microbiosensor of the present invention can be implanted under the skin of a living body to measure physiological parameters of an analyte in a biological fluid. The microbiosensor of the present invention includes two working electrodes made of different conductive materials, one of which can consume interferents that affect the measurement of the biological fluid, so that the other working electrode can obtain a more accurate measurement result during the measurement. [Means for solving the problem]

[0007] According to another aspect of the present disclosure, a microbiosensor for implantation under the skin to perform a measurement of glucose concentration in a biological fluid is disclosed, the microbiosensor reduces interference of at least one interferent in the biological fluid in the measurement. The microbiosensor includes a substrate having a first surface and a second surface disposed oppositely, a first working electrode including a first sensing portion disposed on the first surface of the substrate, the first sensing portion including a first conductive material, a chemical reagent covering at least a portion of the first conductive material of the first sensing portion for reacting with glucose in the biological fluid to produce hydrogen peroxide, and at least one second working electrode including a second sensing portion disposed on the first surface of the substrate, the second sensing portion disposed adjacent to at least one side of the first sensing portion, the second sensing portion including a second conductive material different from the first conductive material. When the first working electrode is driven by a first working voltage, the first sensing portion has a first sensitivity to the hydrogen peroxide and generates a measurement range, the first conductive material reacts with the hydrogen peroxide to generate a current signal, a value of the current signal corresponds to the glucose concentration, a physiological signal is obtained; when the first working electrode is driven by the first working voltage, the first conductive material reacts with the interferent to generate an interference current signal, the interference current signal and the current signal are both output to interfere with the physiological signal; and when the second working electrode is driven by a second working voltage, the second sensing portion has a second sensitivity to the hydrogen peroxide that is less than the first sensitivity, the second sensing portion generates an interference rejection range that contacts the periphery of the first working electrode and at least partially overlaps with the measurement range so as to deplete the interferent and reduce generation of the interference current signal.

[0008] According to another aspect of the present disclosure, a microbiosensor for implantation under the skin to perform a measurement of a physiological parameter of a target analyte in a biological fluid is disclosed, the microbiosensor reducing interference of at least one interferent in the biological fluid in the measurement. The microbiosensor includes a substrate having a surface, a first working electrode including a first sensing portion disposed on the surface, the first sensing portion comprising a first conductive material, at least one second working electrode including a second sensing portion disposed on the surface and adjacent at least one side of the first sensing portion, the second sensing portion comprising a second conductive material, and a chemical reagent covering at least a portion of the first conductive material for reacting with the target analyte in the biological fluid to produce a resultant. The first working electrode is driven by a first working voltage to cause the first conductive material to react with the resultant to output a physiological signal corresponding to the physiological parameter of the target analyte, and the second working electrode is driven by a second working voltage to cause the second conductive material to consume the interferent to reduce the interference to the physiological signal caused by the interferent.

[0009] According to another aspect of the present disclosure, a method for reducing measurement interference of a target analyte is provided, the method including the steps of: providing a micro-biosensor for use in measuring a physiological parameter of the target analyte in a biological fluid, the micro-biosensor comprising a substrate having a surface, a first working electrode including a first sensing portion disposed on the surface, the first sensing portion comprising a first conductive material, at least one second working electrode including a second sensing portion disposed on the surface, the second sensing portion comprising a second conductive material, and a chemical reagent covering at least a portion of the first conductive material for reacting with the target analyte in the biological fluid to produce a resultant product, performing an interference removal operation, the interference removal operation driving the second working electrode with a second working voltage to cause the second conductive material to deplete interferents in the biological fluid and reduce the measurement interference caused by the interferents, and performing a measurement operation, the measurement operation driving the first working electrode with a first working voltage to cause the first conductive material to react with the resultant product and output a physiological signal corresponding to the physiological parameter of the target analyte. [Brief description of the drawings]

[0010] The above embodiments and advantages of the present invention will become more readily apparent to those skilled in the art after reviewing the following detailed description and accompanying drawings. [Figure 1A] FIG. 1 shows a schematic front view of a first embodiment of a microbiosensor of the present invention. [Figure 1B] FIG. 2 shows a schematic diagram of the configuration of a first working electrode and a second working electrode of the first embodiment of the microbiosensor of the present invention. [Figure 2A] 1(A) shows a schematic cross-sectional view of a microbiosensor taken along the cross-sectional line A-A'. [Figure 2B] FIG. 1(A) shows a schematic cross-sectional view of a microbiosensor taken along the section line BB'. [Figure 2C]A schematic cross-sectional view of the microbiosensor taken along the section line C-C' in Figure 1(A) is shown. [Figure 2D] 1 shows a schematic cross-sectional view of a sensing area of ​​a microbiosensor obtained by another manufacturing process. [Figure 3A] FIG. 2 shows a schematic front view of a second embodiment of a microbiosensor of the present invention. [Figure 3B] FIG. 13 shows a schematic diagram of the configuration of a first working electrode and a second working electrode of a second embodiment of a microbiosensor of the present invention. [Figure 4] A schematic cross-sectional view of the microbiosensor taken along the cross-sectional line A-A' in FIG. 3(A) is shown. [Figure 5A] FIG. 13 shows a schematic front view of a third embodiment of a microbiosensor of the present invention. [Figure 5B] A schematic cross-sectional view of a cut field of the microbiosensor along the section line A-A' in FIG. 5(A) is shown. [Figures 6A-6C] 2 shows a schematic diagram of another configuration of the first sensing portion and the second sensing portion of the present invention. [Figure 6D] A schematic cross-sectional view of the microbiosensor taken along the section line I-I' in FIG. 6(C) is shown. [Figure 7] 2 shows a schematic diagram of another configuration of the first sensing portion and the second sensing portion of the present invention. [Figure 8A-8C] 2 shows a schematic diagram of another configuration of the first sensing portion and the second sensing portion of the present invention. [Figure 9A] 1 shows a schematic cross-sectional view of the sensing area of ​​a microbiosensor of the present invention. [Figure 9B] 1 shows a schematic cross-sectional view of the sensing area of ​​a microbiosensor of the present invention. [Figure 10] 1 shows a schematic diagram of the measurement range of the first sensing part and the interference rejection range of the second sensing part after the micro-biosensor of the present invention is activated. [Figure 11] FIG. 1 shows a schematic diagram of an example of a circuit for controlling the voltage and measuring the current of a microbiosensor of the present invention. [Figure 12]1 shows a flow chart of a method for reducing interference occurring during measurement of a microbiosensor of the present invention. [Figures 13A-13C] 13A and 13B show schematic diagrams of the time relationship between interference removal and measurement operations during measurement using the microbiosensor of the present invention, where FIG. 13(A) shows partial overlap of the interference removal and measurement operations, FIG. 13(B) shows no overlap of the interference removal and measurement operations, and FIG. 13(C) shows complete overlap of the interference removal and measurement operations. [Figure 14] FIG. 2 shows a schematic diagram of the time relationship between interference removal and measurement operations during measurement using the microbiosensor of the present invention. [Figure 15] FIG. 2 shows a schematic diagram of the time relationship between interference removal and measurement operations during measurement using the microbiosensor of the present invention. [Figure 16] FIG. 2 shows a schematic diagram of the measurement range of the first sensing portion of the microbiosensor of the present invention after only the first sensing portion is activated. [Figure 17] FIG. 2 is a measurement curve diagram showing the application of the test example of the present invention and the comparative test example to an in vitro interference removal test. When the interference removal function of the second working electrode is activated, the first sensing part is shown as curve C1, and the current signal measured from the second sensing part is shown as curve C2. When the interference removal function of the second working electrode is not activated, the current signal measured by the first sensing part is shown as curve C3. [Figure 18A-18B] The results of an in vivo interference cancellation test are shown, where FIG. 18(A) is the measurement curve without the interference cancellation mechanism, and FIG. 18(B) is the measurement curve with the interference cancellation mechanism. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] The present invention will be described more specifically with reference to the following embodiments. It should be noted that the following descriptions of preferred embodiments are presented herein for the purpose of illustration and description only. They are not intended to be exhaustive or limited to the precise forms disclosed. In the preferred embodiments, the same reference numerals represent the same elements in each embodiment.

[0012] The microbiosensor of the present invention can be a sensor of a continuous glucose monitoring system that is used to be implanted under the skin of a living organism to continuously measure a physiological parameter of a target analyte in a biological fluid. Furthermore, the term "target analyte" referred to herein generally refers to any test substance present in a living organism, such as, but not limited to, glucose, lactose, uric acid, etc. The term "biological fluid" is, but is not limited to, blood or interstitial fluid (ISF), and the term "physiological parameter" is, but is not limited to, concentration.

[0013] 1(A), which is a front schematic view of a first embodiment of a microbiosensor of the present invention. The microbiosensor 10 of the present invention includes a substrate 110 having a surface 111, a first working electrode 120, a second working electrode 130 disposed on the surface 111, and an insulating layer 140 covering a portion of the surface 111, the first working electrode 120, and the second working electrode 130. Referring to FIG. 1(B), the insulating layer 140 has been removed to clearly show the configuration of the first working electrode 120 and the second working electrode 130 on the surface 111 of the substrate 110. The substrate 110 includes a surface 111, an opposite surface 112 (shown in FIG. 2(A), FIG. 9(A), and FIG. 9(B)), a first end 113, a second end 114, and further defines a signal output region 115, a sensing region 116, and an insulating region 117 thereon. The signal output region 115 is disposed in a region close to the first end 113, the sensing region 116 is disposed in a region close to the second end 114, and the insulating region 117 is coated with an insulating layer 140 and disposed in a region between the signal output region 115 and the sensing region 116. The first working electrode 120 and the second working electrode 130 extend from the first end 113 to the second end 114 of the substrate 110. The first working electrode 120 includes a first sensing portion 121 having a first conductive material 1C in the sensing region 116, a first signal output portion 122 (shown in FIG. 1(A)) in the signal output region 115, and a first signal connection portion 123 (shown in FIG. 1(B)) disposed between the first sensing portion 121 and the first signal output portion 122 so as to be partially covered by at least a portion of the insulating region 117. The second working electrode 130 includes a second sensing portion 131 having a second conductive material 2C in the sensing region 116, a second signal output portion 132 (shown in FIG. 1(A)) in the signal output region 115, and a second signal connection portion 133 (shown in FIG. 1(B)) disposed between the second sensing portion 131 and the second signal output portion 132 so as to be covered by at least a portion of the insulating region 117. The second sensing portion 131 of the present invention is adjacent to at least one side of the first sensing portion 121, and the side of the second sensing portion 131 extends along at least one side of the first sensing portion 121. In the first embodiment, the second sensing portion 131 extends along three sides of the first sensing portion 121 to form a U-shaped sensing portion.Therefore, the first sensing portion 121 and the second sensing portion 131 of the present invention maintain a positional relationship therebetween only through the surface 111. The first sensing portion 121 and the second sensing portion 131 of the present invention are directly adjacent to each other, so there are no intermediates such as electrodes or connecting wires.

[0014] To obtain these structures, in the manufacturing process, the second conductive material 2C can be first formed on the surface 111 of the substrate 110 and patterned into a pattern as shown in FIG. 1(B). Specifically, the second conductive material 2C is divided into two separated regions. One of the two regions extending from the first end 113 to the second end 114 of the substrate 110 and bent at the second end 114 to form a U-shaped structure is preset as the second working electrode 130, and the other region extending from the first end 113 to the second end 114 of the substrate 110 and surrounded by the U-shaped structure is preset as the first working electrode 120. After the insulating layer 140 is covered on the substrate 110 and the signal output region 115 and the sensing region 116 are exposed, the first conductive material 1C is formed on the second conductive material 2C of the first working electrode 120 in the sensing region 116 to complete the manufacturing of the first sensing portion 121 of the first working electrode 120. However, although not shown, the first conductive material 1C may be formed only on a portion of the second conductive material 2C of the first working electrode 120 in the sensing region 116. Thus, cross-sectional schematic diagrams of the microbiosensor along the cross-sectional lines AA', B-B', and CC' in FIG. 1 are shown in FIG. 2(A), FIG. 2(B), and FIG. 2(C), respectively. As shown in FIG. 2(A), the first sensing portion 121 of the first embodiment of the present invention has a second conductive material 2C formed on the surface 111 of the substrate and disposed on the first conductive material 1C, and the second sensing portion 131 has the second conductive material 2C. FIG. 2(B) shows the lower region of the U-shaped second sensing portion 131, and thus only the second conductive material 2C is present on the surface 111 of the substrate 110. As shown in FIG. 2(C), since the first conductive material 1C is formed only on the sensing region 116, the portion of the first working electrode 120 located in the insulating region 117 has only the second conductive material 2C and is covered by the insulating layer 140.

[0015] In another embodiment, the step of forming the insulating layer 140 can be performed after forming the first conductive material 1C, so that the first conductive material 1C can be formed substantially on all the second conductive material 2C of the first working electrode 120. Furthermore, the position, size and shape of the second conductive material 2C after the patterning step can be changed according to the requirements of the present invention. Therefore, in another embodiment, the second conductive material 2C can be defined in the patterning step to represent a pattern as shown in FIG. 1(B), but omitted in the area where the first sensing portion 121 is expected to be formed. Specifically, the second conductive material 2C of the first working electrode 120 is only formed in the signal output area 115 and the insulating area 117, or at most partially extends to the sensing area 116. Then, the first conductive material 1C is directly formed on the surface 111 in the area where the first sensing portion 121 is expected to be formed. The first conductive material 1C is electrically connected to other parts of the first working electrode 120 (i.e., the second conductive material 2C) to complete the arrangement of the first working electrode 120. A cross-sectional schematic diagram of the sensing region 116 of the microbiosensor 10 of this embodiment is shown as FIG. 2(D). In another embodiment, the second conductive material 2C in the area where the first working electrode 120 is expected to be formed can be removed in a patterning step. Therefore, the first conductive material 1C can be directly formed on the first working electrode 120 before coating the insulating layer 140 to form the first working electrode 120.

[0016] In the microbiosensor 10 of the present invention, the gap between the second sensing portion 131 and the first sensing portion 121 in the sensing region 116 is 0.2 mm or less. Preferably, the gap is in the range of 0.01 mm to 0.2 mm. More preferably, the gap is in the range of 0.01 mm to 0.1 mm. Even more preferably, the gap is in the range of 0.02 mm to 0.05 mm. Specifically, as shown in FIG. 2(A), in the first embodiment, the gaps S3 and S5 between the first sensing portion 121 and the second sensing portion 131 are both 0.04 mm.

[0017] In the present invention, the first conductive material 1C can be one of carbon, platinum, aluminum, gallium, gold, indium, iridium, iron, lead, magnesium, nickel, molybdenum, osmium, palladium, rhodium, silver, tin, titanium, zinc, silicon, zirconium, their derivatives (such as alloys, oxides or metal compounds), or combinations thereof. The second conductive material 2C can be the elements exemplified in the first conductive material 1C or their derivatives. The material of the insulating layer 140 of the present invention can be any material that can achieve an insulating effect, such as, but not limited to, parylene, polyimide, polydimethylsiloxane (PDMS), liquid crystal polymer material (LCP) or SU-8 photoresist from MicroChem, etc.

[0018] 3(A) and 3(B), FIG. 3(A) is a front schematic view of a second embodiment of the microbiosensor 10 of the present invention, and FIG. 3(B) is a view in which the insulating layer 14 has been removed to clearly show the arrangement of the first working electrode 120 and the second working electrode 130 on the surface 111 of the substrate 110. In the second embodiment, the first working electrode 120 and the second working electrode 130 extend from the first end 113 to the second end 114 of the substrate 110. The part of the first working electrode 120 that is disposed in the sensing region 116 and covered by the first conductive material 1C is the first sensing portion 121, and the part of the second working electrode 130 that is disposed in the sensing region 116 and has the second conductive material 2C is the second sensing portion 131 (shown in FIG. 3(A)). In the second embodiment, the second sensing portion 131 extends along one side of the first sensing portion 121 without bending, so that the second sensing portion 131 is adjacent to only one side of the first sensing portion 121. Thus, a cross-sectional schematic diagram of the microbiosensor along the cross-sectional line A-A′ in Fig. 3(A) is shown in Fig. 4. The first sensing portion 121 of the second embodiment of the present invention has a first conductive material 1C covered with a second conductive material 2C, and the second sensing portion 131 has a second conductive material 2C and is adjacent to the first sensing portion 121 on only one side.

[0019] Please refer to FIG. 5(A), which is a front schematic view of a third embodiment of the microbiosensor of the present invention. In the third embodiment, the microbiosensor 10 has two second working electrodes 130. The first working electrode 120 and the two second working electrodes 130 extend from the first end 113 to the second end 114 of the substrate 110, and the two second working electrodes 130 extend along two opposite sides of the first working electrode 120, respectively. The portion of the first working electrode 120 that is disposed in the sensing region 116 and covered by the first conductive material 1C is the first sensing portion 121, and the portion of the two second working electrodes 130 that is disposed in the sensing region 116 and has the second conductive material 2C is the second sensing portion 131. In the third embodiment, the two second sensing portions 131 are disposed adjacent to two opposite sides of the first sensing portion 121, respectively. Thus, a cross-sectional schematic view of the microbiosensor along the cross-sectional line A-A' in FIG. 5(A) is shown in FIG. 5(B). In the third embodiment of the present invention, the first sensing portion 121 has a first conductive layer 1C covered with a second conductive material 2C, and two second sensing portions 131 have a second conductive material 2C and are adjacent to only two opposite sides of the first sensing portion 121, respectively.

[0020] Although the configurations of the first sensing portion 121 and the second sensing portion 131 of the present invention are described in the first to third embodiments, there can be other configurations. For example, in the first embodiment, the second sensing portion 131 extends along three mutually connected sides of the first sensing portion 121 to form a U-shaped sensing portion. However, in a modified embodiment, the length of the second sensing portion 131 can be adjusted to extend along three sides of the first sensing portion 121, as shown in FIG. 6(A), or the second sensing portion 131 extends along two adjacent sides of the first sensing portion 121 to form an L-shaped sensing portion, as shown in FIG. 6(B). In another modified embodiment of the first embodiment, the first signal connection portion 123 of the first working electrode 120 can be disposed and extended to the opposite surface 112 of the substrate 110 through the through-hole 118 of the substrate 110. Thus, the second sensing portion 131 can surround the four sides of the first sensing portion 121, as shown in FIG. 6(C)-6(D). Whether in the second or third embodiment, the length of the second sensing portion 131 can be changed as shown in Figures 7 to 8(C). Therefore, the above phrase "the second sensing portion 131 is adjacent to at least one side of the first sensing portion 121" specifically means that the ratio of the peripheral portion of the first sensing portion 121 adjacent to the second sensing portion 131 to the entire periphery of the first sensing portion 121 is in the range of 30% to 100%.

[0021] Furthermore, as shown in Figs. 1(A), 2(A), 3(A), 4, 5(A) and 5(B), the micro biosensor 10 of the present invention further includes a chemical reagent layer 150. The chemical reagent layer 150 covers at least the first conductive material 1C of the first sensing portion 121. Specifically, in the manufacturing process of the micro biosensor 10 of the present invention, the substrate 110, which already has electrodes disposed on the surface 111 and / or the opposite surface 112, can be immersed in a solution containing a chemical reagent. The immersion depth of the substrate 110 is adjusted so that the chemical reagent layer 150 can cover the sensing area 116 of the micro biosensor 10 at least once. That is, the chemical reagent layer 150 can cover both the first conductive material 1C of the first sensing portion 121 and the second conductive material 2C of the second sensing portion 131. In another embodiment, the chemical reagent layer 150 can further cover the insulating region 117, as shown in Fig. 1(A). The chemical reagent layer 150 covered with the first conductive material 1C can react with a target analyte in the biological fluid to produce a resultant, and the first conductive material 1C reacts with the resultant to further output a physiological signal corresponding to the target analyte.

[0022] The two working electrode configuration disclosed in the present invention can be applied to two-electrode and three-electrode systems. In a two-electrode system, the microbiosensor 10 of the present invention further includes at least one counter electrode 160 disposed on the opposite surface 112 of the substrate 110, as shown in FIG. 9(A). FIG. 9(A) is a cross-sectional schematic diagram of the sensing area of ​​the microbiosensor. The counter electrode 160 can cooperate with the first working electrode 120 or the second working electrode 130. The counter electrode 160 in a two-electrode system can also function as a reference electrode based on the material used. The counter electrode 160 is bonded to the first working electrode 120 and / or the second working electrode 130. In other embodiments, the counter electrode 160 can be disposed on the surface 111 of the substrate 110 (not shown). In a three-electrode system, the microbiosensor 10 of the present invention further includes a reference electrode 170 used to provide a reference potential, as shown in FIG. 9(B), except for the counter electrode 160. 9(B) is a cross-sectional schematic diagram of the sensing region 116 of the microbiosensor 10. Specifically, the counter electrode 160 and the reference electrode 170 are separate and not electrically connected, and the counter electrode 160 is coupled to the first working electrode 120 and / or the second working electrode 130. The counter electrode 160 and the reference electrode 170 may both be disposed on the surface 111 of the substrate 110 (not shown), or may each be disposed on a different surface of the substrate 110. Also, as shown in FIGS. 9(A)-9(B), the chemical reagent layer 150 is substantially covered on the counter electrode 160 and / or the reference electrode 170.

[0023] It should be noted that the term "driving" in the present invention means applying a voltage that makes the potential of one electrode higher than the potential of the other electrode, so that the electrode with the higher potential initiates the oxidation reaction. Thus, the potential difference between the first working electrode 120 and the counter electrode 160 that drives the first working electrode 120 is the first working voltage, and the potential difference between the second working electrode 130 and the counter electrode 160 that drives the second working electrode 130 is the second working voltage.

[0024] Referring to FIG. 10, the first working electrode 120 of the micro biosensor 10 of the present invention is used to measure a physiological parameter of a target analyte in a biological fluid. When the first working electrode 120 of the micro biosensor 10 is driven by a first working voltage, the first sensing portion generates a measurement range 1S and has a first sensitivity to the resultant, so that the first conductive material 1C reacts with the resultant to generate a current signal. Then, the current signal is transmitted to the signal output portion 122 of the first working electrode 120 via the signal connection portion 123, and the value of the current signal has a proportional relationship with the concentration of the resultant, resulting in a physiological signal corresponding to the physiological parameter. Therefore, when the first working electrode 120 is driven by the first working voltage, the operation of the first conductive material 1C reacting with the resultant to output a physiological signal corresponding to the physiological parameter of the target analyte is defined as a measurement operation. However, there are interferents in the biological fluid, and the first conductive material 1C reacts with the interferent to generate an interference current signal, and the interference current signal and the current signal are output together to interfere with the physiological signal.

[0025] Therefore, the second working electrode 130 of the microbiosensor 10 of the present invention can be applied to deplete the interferents. When the second working electrode 130 of the microbiosensor 10 is driven by a second working voltage, the second conductive material 2C of the second sensing portion 131 has a second sensitivity to the resultant, and each of the second sensing portions 131 generates an interference removal range 2S. The second sensing portions 131 are disposed very close to the first sensing portions 121, so that the interference removal range 2S can contact the periphery of the first sensing portion 121 and at least partially overlap with the measurement range 1S of the first sensing portion 121, respectively. As a result, the second conductive material 2C directly and continuously depletes the interferents by undergoing an oxidation reaction with the interferents, reducing the generation of the interference current signal. This can reduce the influence of the interferents on the measurement operation. Therefore, when the second working electrode 130 is driven by a second working voltage, the operation of depleting the second conductive material 2C of the interferents in the living body is defined as an interference removal operation.

[0026] Furthermore, when the second working electrode 130 is driven by the second working voltage, the second conductive material 2C reacts with the resultant to generate another current signal. This consumes the resultant to be measured by the first working electrode 120 to obtain the physiological parameter of the target analyte. Therefore, the actually measured physiological parameter is affected. Thus, in one embodiment, when the target analyte is glucose, the resultant is hydrogen peroxide, and the physiological parameter is glucose concentration, the first conductive material 1C should preferably be a material having a first sensitivity to hydrogen peroxide after being driven by the first working voltage. More preferably, the first conductive material 1C is selected from the group consisting of gold, platinum, palladium, iridium, and combinations thereof. The second conductive material 2C is different from the first conductive material 1C. Specifically, the second conductive material 2C should preferably be a material having a second sensitivity to hydrogen peroxide lower than the first sensitivity after being driven by the second working voltage. In particular, the second conductive material 2C is a material having little sensitivity to hydrogen peroxide after being driven by the second working voltage, i.e., a second sensitivity close to or equal to zero. More specifically, in one embodiment of the present invention, the first conductive material 1C is platinum, the first operating voltage is in the range of 0.2 volts (V) to 0.8 volts (V), preferably in the range of 0.4 volts (V) to 0.7 volts (V), and the second conductive material 2C is carbon, and the second operating voltage is in the range of 0.2 volts (V) to 0.8 volts (V), preferably in the range of 0.4 volts (V) to 0.7 volts (V). In another embodiment of the present invention, the first conductive material 1C is platinum, and the second conductive material 2C is gold. It should be noted that the form of the aforementioned platinum can be platinum metal, platinum black, platinum paste, other platinum-containing materials, or a combination thereof. Also, the value of the first operating voltage can be the same as the value of the second operating voltage, but the present invention is not limited thereto.

[0027] A method of operating the micro biosensor 10 of the present invention will be further described with reference to Figures 11 and 12. Figure 11 is an example of a circuit for controlling the voltage and measuring the current of the micro biosensor 10 as shown in Figure 9(A) of the present invention. Figure 12 is a flow chart of a method for reducing interference occurring during measurement of the micro biosensor 10 of the present invention. In Figure 11, a current sensing unit 201 is connected to the first working electrode 120 of the micro biosensor 10, and another current sensing unit 202 is connected to the counter electrode 160. The current sensing units 201 and 202 measure current signals i1 and i3 from the first working electrode 120 and the counter electrode 160, respectively, and i2 is a current signal from the second working electrode 130, which can be measured by another current sensing unit (not shown). In this example, the first working voltage is the difference between the potential V1 of the first working electrode 120 and the potential V3 of the counter electrode 160, and the second working voltage is the difference between the potential V2 of the second working electrode 130 and the potential V3 of the counter electrode 160. The switches S1 and S2 respectively enable the first working electrode 120 and the second working electrode 130 to be set to floating. The method for reducing measurement interference of the present invention is shown in Fig. 12, which includes a step S101 of providing a micro-biosensor, a step S102 of performing an interference removal operation, and a step S103 of performing a measurement operation. There is a time relationship between the interference removal operation and the measurement operation, and the possible time sequences are respectively as follows:

[0028] First time relationship: The microbiosensor of the present invention performs measurement during a period T, for example, two weeks, and the period T includes a plurality of first sub-time (T1) zones and / or a plurality of second sub-time (T2) zones. An interference removal operation is performed in each T1 zone, and a measurement operation is performed in each T2 zone. The interference removal operation and the measurement operation are performed alternately. That is, the first time relationship sequentially performs a first interference removal operation in the first T1 zone to consume the interferent. A first measurement operation is performed in the first T2 zone to output a first physiological signal corresponding to the physiological parameter at that time. A second interference removal operation is performed in the second T1 zone to consume the interferent. A second measurement operation is performed in the second T2 zone to output a second physiological signal corresponding to the physiological parameter at that time. Similarly, the value data of the physiological parameter in each T2 zone during the period T is obtained. As shown in Figures 13(A) to 13(C), the horizontal and vertical axes of the figures respectively represent time and current. Here, the line of the measurement operation indicates the application and removal of the first working voltage, and the other line of the interference removal operation indicates the application and removal of the second working voltage. In the first time relationship, the T1 zone and the T2 zone can be at least partially overlapped (as shown in FIG. 13(A)), the T1 zone and the T2 zone can be separated from each other (as shown in FIG. 13(B)), or the T1 zone and the T2 zone can be completely overlapped. That is, the measurement operation and the interference removal operation can be performed simultaneously (as shown in FIG. 13(C)). In the period T, the second working voltage can be removed between any two T1 zones to stop the interference removal operation and separate the two T1 zones, and the first working voltage can be removed between any two T2 zones to stop the measurement operation and separate the two T1 zones. In the first time relationship, the period of the T1 zone is adjusted so that the current signal corresponds to the concentration of the resultant and has a proportional relationship with the physiological parameter. To achieve effective interference removal, the period of the T1 zone is the same as or longer than the period of the T2 zone.

[0029] 13(A)-13(B), the first interference removal operation is preferably performed earlier than or simultaneously with the first measurement operation. Specifically, when there are multiple measurement operations, the interference removal operation is performed at least once, and preferably, the interference removal operation is started before the start of the first measurement operation of the multiple measurement operations.

[0030] Second time relationship: The microbiosensor of the present invention performs measurement during a period T, for example, two weeks, where the period T includes multiple sub-time zones. An interference removal operation is performed throughout the period T, and a measurement operation is performed in each sub-time zone. The measurement operation is performed at intervals. That is, referring to FIG. 14, the second time relationship performs a first interference removal operation continuously throughout the period T to consume the interferent until the end of the period T. Perform the interference removal operation, and perform a first measurement operation in the first sub-time zone to output a first physiological signal corresponding to the physiological parameter at that time. Perform a second measurement operation in the second sub-time zone to output a second physiological signal corresponding to the physiological parameter at that time. Similarly, obtain the value data of the physiological parameter in all different sub-time zones during the period T. There is a time interval between two adjacent sub-time zones. In the period T, the first working voltage can be removed between any two sub-time zones to stop the measurement operation and separate the two sub-time zones. In the second time relationship, the period of each sub-time zone may be the same or different. The duration of each sub-time zone is adjusted so that the current signal corresponds to a concentration of the product and is proportional to a physiological parameter.

[0031] Third time relation: Although not shown, the difference between the third time relation and the second time relation is that the third time relation continues the measurement operation during the entire period T, and performs the interference cancellation operation in each sub-time zone, i.e., alternately performs the interference cancellation operation.

[0032] Fourth time relationship: Referring to Fig. 15, the microbiosensor of the present invention performs measurements during a period T, for example, two weeks. The interference removal operation is continuously performed throughout the period T, and at the same time, the measurement operation is also continuously performed until the end of the period T to continuously deplete the interferents and measure the physiological parameters.

[0033] [In vitro interference removal test] Test Example In this test example, a first embodiment of a microbiosensor having two working electrodes is used, the first sensing portion is a carbon electrode coated with platinum black, the second sensing portion is a carbon electrode, the first working voltage is 0.5 V, the second working voltage is 0.5 V, and the interferent is acetaminophen.

[0034] Comparative test example In this comparative test example, the microbiosensor used in the comparative test example is the same as the test example, but the second working voltage is not provided. Since the second working voltage is not provided, the second sensing portion 131 is not driven, and therefore, there is only the measurement range 1S of the first sensing portion, as shown in FIG.

[0035] The method of the in vitro interference removal test using the microbiosensor of the present invention is as follows. The microbiosensors of the test example and the comparative test example are sequentially immersed in phosphate buffered saline (PBS) solution, 100 mg / dL glucose solution, 40 mg / dL glucose solution, 100 mg / dL glucose solution, 300 mg / dL glucose, 500 mg / dL glucose, 100 mg / dL glucose, 100 mg / dL glucose containing 2.5 mg / dL acetaminophen, 100 mg / dL glucose, and 100 mg / dL glucose containing 5.0 mg / dL acetaminophen for different periods of time (P1 to P9). The results are shown in FIG. 17. The current signal measured from the first sensing portion 121 is shown as curve C1, the current signal measured from the second sensing portion 131 is shown as curve C2 in the test example, and the current signal measured from the first sensing portion 121 is shown as curve C3 in the comparative test example.

[0036] It can be seen from the time periods P1-P5 of FIG. 16. Regardless of the test example or the comparative test example, the first sensing part generates current signals of different intensities according to different glucose concentrations in different periods. That is, there is a proportional relationship between the current signal of the first sensing part and the physiological parameter. However, there is no current signal generated from the second sensing part. This represents that the activity or sensitivity of the second sensing part to hydrogen peroxide, a by-product derived from glucose catalyzed by enzymes, is very low, close to or equal to zero. Furthermore, from the curve C3, when the microbiosensor of the comparative test example is immersed in a 100 mg / dL glucose solution containing 2.5 mg / dL acetaminophen in period P7, compared with the current signal measured in period P3, the current signal measured by the first sensing part 121 in period P7 obviously floats higher due to the influence of interference, and the level of measurement interference becomes even more obvious when the microbiosensor is immersed in a 100 mg / dL glucose solution containing 5 mg / dL acetaminophen in period P9. Conversely, from the curves C1 and C2, when the microbiosensor of the test example is immersed in a 100 mg / dL glucose solution containing 2.5 mg / dL acetaminophen during the period P7, the current signal during the period P7 coincides with the current signal during the period P3. Specifically, when the second working electrode 130 is driven with the second working voltage to perform the interference removal operation, the level at which the first sensing portion 121 is affected by acetaminophen can be reduced even if the concentration of acetaminophen is increased. On the other hand, since the second sensing portion 131 of the second working electrode 130 is used to consume acetaminophen, no current signal is generated in the PBS solution and glucose solution, but a current signal is generated when acetaminophen is present. Therefore, when acetaminophen is present in the measurement environment (i.e., the measurement range), the second sensing portion 131 can consume acetaminophen to reduce the measurement of the first sensing portion that is interfered by acetaminophen, thereby allowing the microbiosensor to measure physiological parameters more accurately.

[0037] In vivo interference removal test In the in vivo interference removal test, a microbiosensor of the first embodiment of the present invention having two working electrodes is used, the first sensing part is a carbon electrode coated with platinum black, the second sensing part is a carbon electrode, the first working voltage is 0.5 V, and the second working voltage is 0.5 V. The microbiosensor is embedded under the skin of a person to continuously monitor the glucose concentration in the interstitial fluid, and 1 g of Panadol, which is mainly composed of acetaminophen, is administered at the 86th hour. Data is measured with and without the interference removal mechanism and compared with the data measured by a conventional blood glucose meter. The results are shown in Figures 18(A) to 18(B). Figure 18(A) is a measurement curve without the interference removal mechanism, Figure 18(B) is a measurement curve without the interference removal mechanism, and Figure 18(B) is a measurement curve with the interference removal mechanism.

[0038] In Figures 18(A)-18(B), the black dots are the values ​​measured by a conventional blood glucose meter, the dotted line is the measurement curve of the first working electrode of the microbiosensor of the present invention, and the solid line is the measurement curve of the second working electrode of the microbiosensor of the present invention. It can be seen from Figure 18(A). In Figure 18(A), it shows that when the interference removal operation is not activated, the value measured by the first working electrode of the microbiosensor of the present invention increases after about 90-96 hours (i.e., 4-6 hours after 1g of Panadol is administered). On the contrary, it can be seen from Figure 18(B). In Figure 18(B), when the interference removal operation is activated, the second sensing part of the microbiosensor of the present invention measures the corresponding current signal, and the value measured by the first working electrode does not increase, which can be matched with the measurement using a conventional blood glucose meter.

[0039] In addition, when the interference removal function of the microbiosensor is activated, the average error value during the period without drug interference is 0.1 mg / dL, the average error value during the period with drug interference is -2.1 mg / dL, the total error value is -1.1 mg / dL, and the mean absolute relative difference (MARD) during the period with drug interference is 4.6. When the interference removal function of the microbiosensor is not activated, the average error value during the period without drug interference is -0.2 mg / dL, the average error value during the period with drug interference is 12.6 mg / dL, the total error value is 6.7 mg / dL, and the mean absolute relative difference (MARD) during the period with drug interference is 10.6. It can be seen that the interference removal operation of the second sensing portion 131 of the second working electrode 130 can actually reduce the interference of the interferent on the physiological signal measured by the first sensing portion 121 to below a certain tolerance (such as 20%, more specifically 10%). In summary, the present invention uses a microbiosensor in which a second sensing portion is positioned adjacent to at least one side of a first sensing portion, whereby the second sensing portion directly and continuously depletes interferents around the first sensing portion, reducing measurement interference of interferents at the first sensing portion and obtaining more accurate data.

[0040] Although the present invention has been described above using the embodiments, the technical scope of the present invention is not limited to the scope described in the above embodiments. It is clear to those skilled in the art that various modifications and improvements can be made to the above embodiments. It is clear from the description of the claims that such modifications and improvements can also be included in the technical scope of the present invention. [Explanation of symbols]

[0041] First conductive material 1C Measurement range: 1S Second conductive material 2C Interference removal range 2S Microbiosensor 10 Substrate 110 Surface 111, 112 First end 113 Second end 114 Signal output area 115 Sensing area 116 Insulation Area 117 First working electrode 120 First sensing part 121 First signal output section 122 First signal connection part 123 Second working electrode 130 Second sensing part 131 Second signal output section 132 Insulating layer 140 Chemical Reagent Layer 150 Counter electrode 160 Reference electrode 170 Current sensing units 201, 202 Current signal i1, i3 Switches S1 and S2 Gap S3, S5 Potential V1, V2, V3

Claims

1. 1. A microbiosensor for use in measuring a physiological parameter of a target analyte in a biological fluid over a period of time, comprising: a substrate having a surface; a first working electrode including a first sensing portion disposed on the surface, the first sensing portion including a first conductive material; at least one second working electrode disposed on the surface and including a second sensing portion, the second sensing portion disposed adjacent to at least one side of the first sensing portion, the second sensing portion including a second conductive material; a chemical reagent covering at least a portion of the first conductive material for reacting with the target analyte in the biological fluid to produce a resultant product; When the first working electrode is driven by a first working voltage, the first sensing portion performs a first electrochemical reaction within the time period and performs a measurement operation until the time period ends; when the second working electrode is driven by a second working voltage, the second sensing portion performs a second electrochemical reaction within the time period, depleting at least one interferent in the biological fluid until the time period ends, and performing an interference removal operation to reduce interference of the interferent with the measurement operation; A microbiosensor, characterized in that multiple signal acquisition operations are performed within the period of time to acquire different representations of the physiological parameter within the period of time by acquiring multiple physiological signals corresponding to the physiological parameter.

2. the second sensing portion is disposed adjacent the gap on the at least one side of the first sensing portion; The gap is 0.2 mm or less, The microbiosensor of claim 1, characterized in that the second sensing portion is adjacent to at least two adjacent sides of the first sensing portion, one side of the second sensing portion extends along a periphery of the first sensing portion, and a portion of a side of the first sensing portion adjacent to the second sensing portion occupies a range of 30% to 100%.

3. The microbiosensor described in claim 1, characterized in that the interference removal operation and the measurement operation are performed simultaneously or alternately.

4. A microbiosensor as described in claim 1, characterized in that when there are multiple measurement operations, the interference removal operation is performed at least once, and the interference removal operation is started before the start of a first measurement operation of the multiple measurement operations.

5. The microbiosensor described in claim 1, characterized in that when the interference removal operation is performed only once, the start of the interference removal operation is earlier than the measurement period of at least a single of the measurement operation.

Citation Information

Patent Citations

  • Enzyme electrode

    JP1982118152A

  • Method and device for measuring concentration

    JP1997189676A

  • How to Apply Two Different Potentials to Reduce Interference in Electrochemical Sensors

    JP2007514927A

  • Analyte sensor with increased reference capacity

    US20130245412A1